Displaying drugs 13826 - 13850 of 15349 in total
AP-101
AP-101 is a recombinant human antibody directed against human misfolded superoxide dismutase 1.
Investigational
OT-15
Investigational
ABO-201
Investigational
Human ciliary neurotrophic factor, recombinant (E. coli)
Investigational
Tonabacase
Investigational
C-Alpha-stx1
Investigational
Tabituximab barzuxetan yttrium Y-90
A version of tabituximab barzuxetan radiolabeled with yttrium-90.
Investigational
Yttrium Y-90 Labetuzumab
Investigational
Allogenic bone marrow-derived mesenchymal stem cells
Investigational
BHT-3034
BHT-3034 is a DNA plasmid vaccine immunotherapy under investigation for the treatment of myasthenia gravis.
Investigational
SIS-101-ADO
SIS-101-ADO is a siRNA therapeutic under investigation for the treatment of Autosomal Dominant Osteopetrosis Type 2 (ADO2).
Investigational
PBKR03
PBKR03 is a non-replicating recombinant adeno-associated virus serotype hu68 vector, containing a transgene encoding the human galactosylceramidase (GALC) enzyme.
Investigational
ATX-01
ATX-01 is an antimiR, a chemically modified antisense oligonucleotide, designed to target microRNA 23b (miR-23b).
Investigational
Gentulizumab
Investigational
Zilganersen
Investigational
ION283
Investigational
LipidRescue
Investigational
LYT-200
LYT-200 is a fully human IgG4 monoclonal antibody directed against galectin-9.
Investigational
Ersodetug
Investigational
NBL-015
Investigational
OM-301
Investigational
ACT-1 peptide
Investigational
FCX-013
FCX-013 consists of human dermal fibroblasts genetically modified with a lentiviral vector expressing metalloproteinase-1 (MMP-1).
Investigational
INO-3107
Investigational
Displaying drugs 13826 - 13850 of 15349 in total